Skip to main content
Premium Trial:

Request an Annual Quote

Strand and Pharmidex to Co-Promote, Co-Develop BBB Research Tools

NEW YORK, Feb. 21 (GenomeWeb News) - Strand Life Sciences and Pharmidex have entered into a co-marketing and -product development agreement, the companies said today.


Under the terms of the agreement, Strand and Pharmidex will promote each other's existing products and jointly develop new software to predict the ability of compounds to cross the blood-brain barrier, the companies said.


Strand will primarily provide in silico expertise, while Pharmidex will contribute its expertise in blood-brain barrier research, including in vitro, ex vivo, and in vivo methods.


Financial terms of the agreement were not disclosed.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.